Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of ...

Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

Merck’s MRK fourth-quarter revenue grew 7% to $15.6 billion (including Keytruda growth of 21% to $7.8 billion), in line with ...

Merck's stock tumbled 11.8% Tuesday, putting it on track for its biggest one-day selloff in almost 17 years, after the drug company's softer-than-expected guidance amid struggles for its HPV vaccine ...

In conjunction with Cervical Cancer Awareness Month, it is crucial to highlight the introduction of the Human Papillomavirus (HPV) vaccine, which has transformed cervical cancer prevention ...

The hepatitis B vaccine is a shot, typically injected into the arm, that protects against hepatitis B in babies, children, and adults. It is an important way to protect yourself and your children from ...

including more than 30 years of research and development along with real world evidence generated by Merck and by independent investigators, continues to support the safety and efficacy of our HPV ...

Kennedy, Jr. – the vaccine skeptic President ... Wisner Baum is currently suing Merck over Gardasil – which is administered to young people to prevent HPV, the human papillomavirus – with ...

a law firm suing Merck over claims that the pharmaceutical company failed to properly warn consumers about risks from its HPV vaccine, Gardasil, according to new filings with the Office of ...